M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 51.06 USD -1.6% Market Closed
Market Cap: 3.3B USD
Have any thoughts about
MoonLake Immunotherapeutics?
Write Note

MoonLake Immunotherapeutics
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MoonLake Immunotherapeutics
Income from Continuing Operations Peer Comparison

Comparables:
ADCT
ACIU
CRSP
MOLN
XLS

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
M
MoonLake Immunotherapeutics
NASDAQ:MLTX
Income from Continuing Operations
-$44.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Income from Continuing Operations
-$234.5m
CAGR 3-Years
2%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Income from Continuing Operations
-CHf60.5m
CAGR 3-Years
7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Income from Continuing Operations
-$239.6m
CAGR 3-Years
N/A
CAGR 5-Years
-84%
CAGR 10-Years
N/A
Molecular Partners AG
SIX:MOLN
Income from Continuing Operations
-CHf69.1m
CAGR 3-Years
1%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Xlife Sciences AG
SIX:XLS
Income from Continuing Operations
CHf9.3m
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MoonLake Immunotherapeutics's Income from Continuing Operations?
Income from Continuing Operations
-44.1m USD

Based on the financial report for Dec 31, 2023, MoonLake Immunotherapeutics's Income from Continuing Operations amounts to -44.1m USD.

What is MoonLake Immunotherapeutics's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 1Y
32%

Over the last year, the Income from Continuing Operations growth was 32%.

Back to Top